History of the Orthopaedic Oncology Service at MGH
Dr. Henry J. Mankin
conversation with Dr. Mankin
Dr. Henry J. Mankin established the Orthopaedic Oncology Service at MGH in 1972. During his time as Chief of the Oncology Service, Dr. Mankin stressed the importance of research guiding clinical practice. Through his research, Dr. Mankin reintroduced bone transplantation and bone allograft transplants to treat and cure patients with life-threatening bone and soft tissue malignancies and established a computer system for tracking orthopaedic oncology patients and gathering clinical information. Dr. Mankin’s scholarly achievements have formed the foundation for much of the standard of orthopaedic practice today. Dr. Mankin’s commitment to research was evident throughout his career and in the more than 500 peer-reviewed articles he published.
Dr. Mankin is a world-renowned orthopaedic surgeon who has always been committed to sharing his knowledge of the musculoskeletal system. He was a dedicated teacher, tireless researcher and compassionate clinician. Dr. Mankin stepped down as Chief of the Orthopaedic Oncology Service in 2000, and Dr. Francis Hornicek was appointed Chief.
Our Orthopaedic Oncology team includes:
Dr. Hornicek has continued Dr. Mankin’s legacy of commitment to education, research and his patients. In 2007, Dr. Hornicek received the 2007 Brian McGovern Award for Clinical Excellence at MGH. The McGovern honor is given to a physician for their dedication, patient-centered care and clinical excellence. In addition to his role as Chief of the Orthopaedic Oncology Service, Dr. Hornicek is Co-Director of the Center for Sarcoma and Connective Tissue Oncology, Director of the Stephan L. Harris Chordoma Center and Co-Leader of the Dana Farber/Harvard Cancer Center Sarcoma Group.
Dr. Kevin Raskin balances his practice with a combination of clinical work, educational endeavors and research. Dr. Raskin is the Director of the Musculoskeletal Oncology Fellowship at MassGeneral, teaches multiple courses at Harvard Medical School and is an active educator for medical students, residents and fellows. His clinical work is focused on treating patients with benign and malignant bone tumors. Dr. Raskin’s research is focused on the outcome of orthopaedic oncology surgeries. This information is stored in a database that houses outcomes on 16,000 other orthopaedic oncology patients.
Dr. Joseph Schwab works in both the Orthopaedic Oncology Service and the Orthopaedic Spine Service. He is serving at the Interim Director of the Spine Service. Dr. Schwab has an active practice that includes the management of benign and malignant bone tumors, as well as maladies of the spine such as cervical spinal stenosis, cervical myelopathy, lumbar steonsis, lumbar spondylolisthesis, herniated discs and adult scoliosis. Dr. Schwab’s research interests are in chordoma, and he recently received a Masters in Clinical Investigation from the School of Health Sciences and Technology at Harvard Medical School and MIT.
Anne Fiore, NP was the first Advanced Practitioner to be hired in the Orthopaedic Service in 1992. She works closely with Drs. Hornicek, Raskin and Schwab to support, educate, coordinate treatment, manage care and navigate patients and families through the health care system. Anne cares for children, adolescents, and adults with primary bone or soft tissue tumors, benign and malignant, as well as metastatic disease. She routinely collaborates with all members of the MGH Sarcoma team in medical oncology, radiation oncology, MSK radiology and pathology.